ApprovalTrail

Approval · Notice of Compliance 5324 · 1994

ARVIN: Notice of Compliance 5324

Issued May 13, 1994

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
5324
Date
May 13, 1994
Company
Knoll Pharma Inc.Markham, Ontario, Canada
Product type
Biologic
Submission
New Drug Submission (NDS)
Submission class
Admin
Therapeutic class
Anticoagulant

Products in this notice

BrandDINStatus today
ARVIN00657271Cancelled Post Market

Medicinal ingredients